Journal article
Influence of disodium etidronate on Paget's disease of bone.
Abstract
The use of agents that decrease bone resorption, notably the calcitonins, diphosphonates and mithramycin, has been shown to result in symptomatic and/or biochemical improvement in patients with Paget's disease of bone (osteitis deformans). The effects of short-term (6 months), low-dose (5 mg/kg body mass/d) etidronate disodium, a diphosphonate compound at present subject to registration in this country, on the clinical and laboratory …
Authors
Muir HG; Schabort I; Hough FS
Journal
South African Medical Journal, Vol. 72, No. 7, pp. 470–472
Publication Date
October 3, 1987
ISSN
0256-9574